Immunological and molecular signatures of carbamazepine-induced maculopapular exanthema.
Saved in:
| Title: | Immunological and molecular signatures of carbamazepine-induced maculopapular exanthema. |
|---|---|
| Authors: | Mullan KA; Department of Biochemistry and Molecular Biology, Infection and Immunity Programs, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Department of Electrical and Electronic Engineering, University of Melbourne, Melbourne, VIC, Australia., Davies S; Department of Biochemistry and Molecular Biology, Infection and Immunity Programs, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Teoh K; Department of Biochemistry and Molecular Biology, Infection and Immunity Programs, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia., Tucker HL; Department of Biochemistry and Molecular Biology, Infection and Immunity Programs, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Lai JW; Department of Biochemistry and Molecular Biology, Infection and Immunity Programs, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Anderson A; Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia.; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Todaro M; Faculty of Medicine, The University of Melbourne, Melbourne, VIC, Australia.; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Ng CC; Institute of Biological Sciences, Faculty of Science, Universiti Malaya, Kuala Lumpur, Malaysia., Lim KS; Division of Neurology, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Kern JS; Department of Dermatology, Bayside Health, The Alfred and Department of Immunology, The School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Kwan P; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Department of Neurology, Alfred Health, Melbourne, VIC, Australia.; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China., Illing PT; Department of Biochemistry and Molecular Biology, Infection and Immunity Programs, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Purcell AW; Department of Biochemistry and Molecular Biology, Infection and Immunity Programs, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Mifsud NA; Department of Biochemistry and Molecular Biology, Infection and Immunity Programs, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 26; Vol. 17, pp. 1818888. Date of Electronic Publication: 2026 Jun 26 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1818888 |
